Ferran Nadeu

54PUBLICATIONS
244CO-AUTHORS
Liquid biopsiesHaematological tumoursPredictive and prognostic markersDevelopmental genetics (incl. sex determination)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Sep 22, 2025
Increased LEF1 protein levels and isoform switching drive cell proliferation in chronic lymphocytic leukemia.

Judith Mateos-Jaimez, Anna Vidal-Crespo, Stella Charalampopoulou

|Sep 10, 2025
Fluctuating DNA methylation tracks cancer evolution at clinical scale.

Calum Gabbutt, Martí Duran-Ferrer, Heather E Grant

|Jun 30, 2025
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Ferran Nadeu, Shimin Shuai, Guillem Clot

|Apr 24, 2025
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.

Birna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton

|Jan 22, 2025
Dual biological role and clinical impact of de novo chromatin activation in chronic lymphocytic leukemia.

Vicente Chapaprieta, Alba Maiques-Diaz, Ferran Nadeu

Pageof 9